{
    "Trade/Device Name(s)": [
        "DiaSorin LIAISON\u00ae TOXO IgM",
        "DiaSorin LIAISON\u00ae TOXO IgG",
        "LIAISON\u00ae Toxo IgM",
        "LIAISON\u00ae Toxo IgG"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K052499",
    "Predicate Device Reference 510(k) Number(s)": [
        "K963289",
        "K981498"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LGD"
    ],
    "Summary Letter Date": "February 8, 2006",
    "Summary Letter Received Date": "January 6, 2006",
    "Submission Date": "January 5, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.3780"
    ],
    "Regulation Name(s)": [
        "Toxoplasma gondii Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "IgM antibodies to Toxoplasma gondii",
        "IgG antibodies to Toxoplasma gondii"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)",
        "Enzyme Linked Immunosorbent Assay (ELISA)"
    ],
    "Methodologies": [
        "Antibody capture CLIA",
        "Indirect CLIA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON TOXO IgM and IgG chemiluminescent immunoassays for qualitative detection of antibodies to Toxoplasma gondii in human serum",
    "Indications for Use Summary": "Qualitative determination of specific IgM or IgG antibodies to Toxoplasma gondii in human serum, aiding in presumptive diagnosis of acute or recent infection or assessment of serological immune status including in pregnant women; not for blood/plasma donor screening.",
    "fda_folder": "Microbiology"
}